Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 2–Toll-like receptor 1 heterodimer is a cell-surface pattern recognition receptor complex composed of TLR2 and TLR1 subunits. This heterodimer, primarily located on immune cells such as macrophages and dendritic cells, recognizes specific microbial components, notably triacylated lipopeptides from bacteria, leading to activation of the innate immune response[3][4][6]. Ligand binding induces the formation of an “m”-shaped extracellular domain arrangement, driving close apposition of intracellular TIR (Toll/interleukin-1 receptor) domains and triggering downstream signaling involving the adapter protein MyD88, resulting in production of pro-inflammatory cytokines and type I interferons[4][5][6]. This receptor complex is crucial for early defense against pathogens but is also implicated in inflammatory and autoimmune pathology when dysregulated[3][7][8]. Experimental agonists like Pam3CSK4 and CU-T12-9 specifically activate the TLR2/1 dimer, and its modulation is under investigation for various infectious, inflammatory, and oncological conditions[6][8].
Agonists or ligands induce dimerization, triggering downstream signaling via MyD88 and activation of NF-κB and inflammatory cytokine production; Recognition of triacylated lipopeptides and subsequent immune activation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 2–Toll-like receptor 1 heterodimer (TLR2–TLR1 heterodimer).